Search

Your search keyword '"Newcastle disease virus growth & development"' showing total 446 results

Search Constraints

Start Over You searched for: Descriptor "Newcastle disease virus growth & development" Remove constraint Descriptor: "Newcastle disease virus growth & development"
446 results on '"Newcastle disease virus growth & development"'

Search Results

1. Mutations in the Methyltransferase Motifs of L Protein Attenuate Newcastle Disease Virus by Regulating Viral Translation and Cell-to-Cell Spread.

2. Newcastle Disease Virus Entry into Chicken Macrophages via a pH-Dependent, Dynamin and Caveola-Mediated Endocytic Pathway That Requires Rab5.

3. Activation of the extracellular signal-regulated kinase pathway is required for replication of Newcastle disease virus.

4. NDV-D90 inhibits 17β-estradiol-mediated resistance to apoptosis by differentially modulating classic and nonclassic estrogen receptors in breast cancer cells.

5. Benefit of Dietary Supplementation with Bacillus subtilis BYS2 on Growth Performance, Immune Response, and Disease Resistance of Broilers.

6. Experimental pigeon paramyxovirus-1 infection in chicken: evaluation of infectivity, clinical and pathological manifestations and diagnostic methods.

7. eIF2α-CHOP-BCl-2/JNK and IRE1α-XBP1/JNK signaling promote apoptosis and inflammation and support the proliferation of Newcastle disease virus.

8. Newcastle Disease Virus Nonstructural V Protein Upregulates SOCS3 Expression to Facilitate Viral Replication Depending on the MEK/ERK Pathway.

9. Establishment and characterization of an immortalized renal cell line of the Chinese tree shrew (Tupaia belangeri chinesis).

10. Detection of viral components in exosomes derived from NDV-infected DF-1 cells and their promoting ability in virus replication.

11. Host immune responses of pigeons infected with Newcastle disease viruses isolated from pigeons.

12. The virulence of NDV NA-1 strain regulated by the 3' leader or 5' trailer sequences.

13. Newcastle Disease Virus V Protein Inhibits Cell Apoptosis and Promotes Viral Replication by Targeting CacyBP/SIP.

14. Oncolytic effect of wild-type Newcastle disease virus isolates in cancer cell lines in vitro and in vivo on xenograft model.

15. Newcastle disease virus co-expressing interleukin 7 and interleukin 15 modified tumor cells as a vaccine for cancer immunotherapy.

16. In vitro infectivity of oncolytic Newcastle Disease Virus: Correlation between plaque and fluorescent focus assays.

17. Ethanol extract and chromatographic fractions of Tamarindus indica stem bark inhibits Newcastle disease virus replication.

18. Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells In Vitro : Contribution of the Cleavage Site of Fusion Protein and Second Sialic Acid Binding Site of Hemagglutinin-Neuraminidase.

19. NDV-D90 suppresses growth of gastric cancer and cancer-related vascularization.

20. Clinicopathological characterization of experimental infection in chickens with sub-genotype VIIi Newcastle disease virus isolated from peafowl.

21. Virus inactivation under the photodynamic effect of phthalocyanine zinc(II) complexes.

22. Derivation of chicken induced pluripotent stem cells tolerant to Newcastle disease virus-induced lysis through multiple rounds of infection.

23. An improved reverse genetics system for Newcastle disease virus genotype VII.

24. Newcastle disease virus chimeras expressing the Hemagglutinin- Neuraminidase protein of mesogenic strain exhibits an enhanced anti-hepatoma efficacy.

25. Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy.

26. Experimental infection with Brazilian Newcastle disease virus strain in pigeons and chickens.

27. Evolution of Newcastle Disease Virus Quasispecies Diversity and Enhanced Virulence after Passage through Chicken Air Sacs.

28. The therapeutic effect of death: Newcastle disease virus and its antitumor potential.

29. Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway.

30. Assessment of the pathogenicity of cell-culture-adapted Newcastle disease virus strain Komarov.

31. Newcastle Disease Virus-Vectored H7 and H5 Live Vaccines Protect Chickens from Challenge with H7N9 or H5N1 Avian Influenza Viruses.

32. Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma.

33. Field distribution of END phenomenon-negative bovine viral diarrhea virus.

34. Inactivation of avian influenza virus, newcastle disease virus and goose parvovirus using solution of nano-sized scallop shell powder.

35. Viral persistence in colorectal cancer cells infected by Newcastle disease virus.

36. Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer.

37. Scutellaria polysaccharide inhibits the infectivity of Newcastle disease virus to chicken embryo fibroblast.

38. Induction of apoptosis in MCF-7 cells by the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus Malaysian strain AF2240.

39. Evaluation of the U.S. Department of Agriculture's egg pasteurization processes on the inactivation of high-pathogenicity avian influenza virus and velogenic Newcastle disease virus in processed egg products.

40. Newcastle disease virus Malaysian strain AF2240 induces apoptosis in MCF-7 human breast carcinoma cells at an early stage of the virus life cycle.

41. Functional characterization of domains of IPS-1 using an inducible oligomerization system.

42. Engagement of new castle disease virus (NDV) matrix (M) protein with charged multivesicular body protein (CHMP) 4 facilitates viral replication.

43. In vitro characterization of the antiviral activity of fucoidan from Cladosiphon okamuranus against Newcastle Disease Virus.

44. Structure and assembly of a paramyxovirus matrix protein.

45. Velogenic newcastle disease virus as an oncolytic virotherapeutics: in vitro characterization.

46. Synthesis, antimicrobial, and antiviral activities of some new 5-sulphonamido-8-hydroxyquinoline derivatives.

47. Newcastle disease virus induces apoptosis in cisplatin-resistant human lung adenocarcinoma A549 cells in vitro and in vivo.

49. [Construction and rescue of infectious cDNA clone of pigeon-origin Newcastle disease virus strain JS/07/04/Pi].

50. A single amino acid change, Q114R, in the cleavage-site sequence of Newcastle disease virus fusion protein attenuates viral replication and pathogenicity.

Catalog

Books, media, physical & digital resources